BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

585 related articles for article (PubMed ID: 27059609)

  • 1. α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy.
    Ettle B; Kerman BE; Valera E; Gillmann C; Schlachetzki JC; Reiprich S; Büttner C; Ekici AB; Reis A; Wegner M; Bäuerle T; Riemenschneider MJ; Masliah E; Gage FH; Winkler J
    Acta Neuropathol; 2016 Jul; 132(1):59-75. PubMed ID: 27059609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endogenous oligodendroglial alpha-synuclein and TPPP/p25α orchestrate alpha-synuclein pathology in experimental multiple system atrophy models.
    Mavroeidi P; Arvanitaki F; Karakitsou AK; Vetsi M; Kloukina I; Zweckstetter M; Giller K; Becker S; Sorrentino ZA; Giasson BI; Jensen PH; Stefanis L; Xilouri M
    Acta Neuropathol; 2019 Sep; 138(3):415-441. PubMed ID: 31011860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. α-Synuclein impairs oligodendrocyte progenitor maturation in multiple system atrophy.
    May VE; Ettle B; Poehler AM; Nuber S; Ubhi K; Rockenstein E; Winner B; Wegner M; Masliah E; Winkler J
    Neurobiol Aging; 2014 Oct; 35(10):2357-68. PubMed ID: 24698767
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCAS1-positive immature oligodendrocytes are affected by the α-synuclein-induced pathology of multiple system atrophy.
    Kaji S; Maki T; Ueda J; Ishimoto T; Inoue Y; Yasuda K; Sawamura M; Hikawa R; Ayaki T; Yamakado H; Takahashi R
    Acta Neuropathol Commun; 2020 Jul; 8(1):120. PubMed ID: 32727582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligodendroglial α-synucleinopathy-driven neuroinflammation in multiple system atrophy.
    Hoffmann A; Ettle B; Battis K; Reiprich S; Schlachetzki JCM; Masliah E; Wegner M; Kuhlmann T; Riemenschneider MJ; Winkler J
    Brain Pathol; 2019 May; 29(3):380-396. PubMed ID: 30444295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegeneration in a transgenic mouse model of multiple system atrophy is associated with altered expression of oligodendroglial-derived neurotrophic factors.
    Ubhi K; Rockenstein E; Mante M; Inglis C; Adame A; Patrick C; Whitney K; Masliah E
    J Neurosci; 2010 May; 30(18):6236-46. PubMed ID: 20445049
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurological and neurodegenerative alterations in a transgenic mouse model expressing human alpha-synuclein under oligodendrocyte promoter: implications for multiple system atrophy.
    Shults CW; Rockenstein E; Crews L; Adame A; Mante M; Larrea G; Hashimoto M; Song D; Iwatsubo T; Tsuboi K; Masliah E
    J Neurosci; 2005 Nov; 25(46):10689-99. PubMed ID: 16291942
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of α-Synuclein by Oligodendrocytes in Transgenic Mice Does Not Recapitulate the Fibrillar Aggregation Seen in Multiple System Atrophy.
    Laferrière F; He X; Zinghirino F; Doudnikoff E; Faggiani E; Meissner WG; Bezard E; De Giorgi F; Ichas F
    Cells; 2020 Oct; 9(11):. PubMed ID: 33138150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sobetirome rescues α-synuclein-mediated demyelination in an in vitro model of multiple system atrophy.
    Mészáros L; Himmler M; Schneider Y; Arnold P; Dörje F; Schubert DW; Winkler J
    Eur J Neurosci; 2024 Jan; 59(2):308-315. PubMed ID: 38086536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rifampicin reduces alpha-synuclein in a transgenic mouse model of multiple system atrophy.
    Ubhi K; Rockenstein E; Mante M; Patrick C; Adame A; Thukral M; Shults C; Masliah E
    Neuroreport; 2008 Aug; 19(13):1271-6. PubMed ID: 18695506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prodegenerative IκBα expression in oligodendroglial α-synuclein models of multiple system atrophy.
    Kragh CL; Gysbers AM; Rockenstein E; Murphy K; Halliday GM; Masliah E; Jensen PH
    Neurobiol Dis; 2014 Mar; 63():171-83. PubMed ID: 24361600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel oligodendroglial alpha synuclein viral vector models of multiple system atrophy: studies in rodents and nonhuman primates.
    Mandel RJ; Marmion DJ; Kirik D; Chu Y; Heindel C; McCown T; Gray SJ; Kordower JH
    Acta Neuropathol Commun; 2017 Jun; 5(1):47. PubMed ID: 28619074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human alpha-synuclein overexpressing MBP29 mice mimic functional and structural hallmarks of the cerebellar subtype of multiple system atrophy.
    Mészáros L; Riemenschneider MJ; Gassner H; Marxreiter F; von Hörsten S; Hoffmann A; Winkler J
    Acta Neuropathol Commun; 2021 Apr; 9(1):68. PubMed ID: 33853667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse model of multiple system atrophy alpha-synuclein expression in oligodendrocytes causes glial and neuronal degeneration.
    Yazawa I; Giasson BI; Sasaki R; Zhang B; Joyce S; Uryu K; Trojanowski JQ; Lee VM
    Neuron; 2005 Mar; 45(6):847-59. PubMed ID: 15797547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viral-mediated oligodendroglial alpha-synuclein expression models multiple system atrophy.
    Bassil F; Guerin PA; Dutheil N; Li Q; Klugmann M; Meissner WG; Bezard E; Fernagut PO
    Mov Disord; 2017 Aug; 32(8):1230-1239. PubMed ID: 28556404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cystatin C triggers neuronal degeneration in a model of multiple system atrophy.
    Suzuki Y; Jin C; Yazawa I
    Am J Pathol; 2014 Mar; 184(3):790-9. PubMed ID: 24405769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of α-synuclein in oligodendrocytes does not increase susceptibility to focal striatal excitotoxicity.
    Kuzdas-Wood D; Fellner L; Premstaller M; Borm C; Bloem B; Kirik D; Wenning GK; Stefanova N
    BMC Neurosci; 2015 Dec; 16():86. PubMed ID: 26627686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cellular iron deposition patterns predict clinical subtypes of multiple system atrophy.
    Lee S; Martinez-Valbuena I; Lang AE; Kovacs GG
    Neurobiol Dis; 2024 Jul; 197():106535. PubMed ID: 38761956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A mouse model of adult-onset multiple system atrophy.
    Tanji K; Miki Y; Mori F; Nikaido Y; Narita H; Kakita A; Takahashi H; Wakabayashi K
    Neurobiol Dis; 2019 Jul; 127():339-349. PubMed ID: 30910745
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reducing C-terminal truncation mitigates synucleinopathy and neurodegeneration in a transgenic model of multiple system atrophy.
    Bassil F; Fernagut PO; Bezard E; Pruvost A; Leste-Lasserre T; Hoang QQ; Ringe D; Petsko GA; Meissner WG
    Proc Natl Acad Sci U S A; 2016 Aug; 113(34):9593-8. PubMed ID: 27482103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.